Abstract
An Escherichia coli library containing cDNA sequences derived from mRNA of human pharnygeal carcinoma cells was constructed using the plasmid pBR322. The library was screened with a set of 8 deoxyoligonucleotides, 14 bases in length, which collectively code for the amino acid sequence …Met-Tyr-Asn-Asp-Pro… found in human urokinase (u-PA). A plasmid containing an ∼1700 base pair cDNA insert coding for the carboxy terminal sequence of u-PA was identified. The 5′ region was obtained by priming poly(A) mRNA with a DNA fragment derived from the initial clone. An expression vector was constructed which directs the synthesis of pro u-PA in E. coli.
Similar content being viewed by others
References
Collen, D. 1980. On the regulation and control of fibrinolysis. Thrombos. Haemostas. 43: 77–89.
Rijken, D.C. and Collen, D. 1981. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J. Biol. Chem. 256: 7035–7041.
Wallen, P., Ranby, M., Bergsdorf, N. and Kok, P. 1981. Purification and characterization of tissue plasminogen activator: on the occurrence of two different forms and their enzymatic properties, p. 16–23. In: Progress in Fibrinolysis, Volume 5. Davidson, J. F., Nilsson, I. M., and Astedt, B. (eds.). Churchill Livingstone, Edinburgh.
White, W.F., Barlow, G.H. and Mozen, M.M. 1966. The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 5: 2160–2169.
Barlow, G.H., Lazer, L., Rueter, A. and Tribby, I. 1977. Production of Plasminogen Activator by tissue culture techniques, p. 758. In: Thrombosis and Urokinase. Paoletti, R. and Sherry, S. (eds.). Academic Press, NY.
Kohno, T., Hopper, P., Lillquist, J.S., Suddith, R.L., Greenlee, R. and Moir, D.L. 1984. Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity. Bio/Technology 2: 628–634.
Wun, T.-C., Schleuning, W.-D. and Reich, E. 1982. Isolation and characterization of urokinase from human plasma. J. Biol. Chem. 257: 3276–3283.
Wun, T.-C., Ossowski, L. and Reich, E. 1982. A proenzyme form of human urokinase. J. Biol. Chem. 257: 7262–7268.
Straszburger, W., Wollmer, A., Pitts, J.E., Glover, I.D., Tickle, I.J., Blundell, T.L., Steffens, G.J., Gunzler, W.A., Oetting, F. and Flohé, L. 1983. Adaption of plasminogen activator sequences to known protease structures. FEBS Lett. 157: 219–223.
Guenzler, W., Steffens, G., Oetting, F., Buse, G. and Flohé, L. 1982. Structural relationship between human high and low molecular weight mass urokinase. Hoppe-Seyler's Z. Physiol. Chem. 363: 133–141.
Verstraete, M. 1980. A far-reaching program: rapid, safe and predictable thrombolysis in man, p. 185–200. In: Fibrinolysis, Kline, D. L. and Reddy, K. N. N. (eds.). CRC Press, Boca Raton, FL.
Pennica, D., Holmes, W.E., Kohr, W.J., Harkins, R.N., Vehar, G.A., Ward, C.A., Bennett, W.F., Yelverton, E., Seeburg, P.H., Heyneker, H.L., Goeddel, D.V. and Collen, D. 1983. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301: 214–221.
Vetterlein, D., Bell, T.E., Young, P.L. and Roblin, R. 1980. Immunological quantitation and immunoadsorption of urokinase-like plasminogen activators secreted by human cells. J. Biol. Chem. 255: 3665–3672.
Lynch, K.R., Pennica, D., Ennis, H.L. and Cohen, P.S. 1979. Separation and purification of the mRNAs for vesicular stomatitis virus NS and M proteins. Virology 98: 251–254.
Lawn, R.M., Adelman, J., Bock, S.C., Franke, A.E., Houck, C.M., Najarian, R.C., Seeburg, P.H. and Wion, K.L. 1981. The sequence of human serum albumin and its expression in E. coli. Nucl. Acids. Res. 9: 6103–6114.
Backman, K., Ptashne, M. and Gilbert, W. 1976. Construction of plasmids carrying the cI gene of bacteriophage lambda. Proc. Natl. Acad. Sci., USA 73: 4174–4178.
Steffens, G.J., Guenzler, W.A., Oetting, F., Frankus, E. and Flohé, L. 1982. The complete amino acid sequence of low molecular mass urokinase from human urine. Hoppe-Seyler's Z. Physiol. Chem. 363: 1043–1058.
Wallace, R.B., Johnson, M.J., Hirose, T., Miyake, T., Kawashima, E.H. and Itakura, K. 1981. The use of synthetic oligonucleotides as hybridization probes II. Hybridization of oligonucleotides of mixed sequence to rabbit β-globin DNA. Nucl. Acids Res. 9: 879–894.
Proudfoot, N.J. and Brownlee, G.G. 1976. 3′ Non-coding region sequences in eukariotic messenger RNA. Nature 263: 211–214.
deBoer, H.A., Comstock, L.J., Yansura, D.G. and Heyneker, H.L. 1982. Construction of a tandem trp-lac promoter and hybrid trp-lac promoter for efficient and controlled expression of the human growth hormone gene in Escherichia coli, p. 462–481. In: Promoters: Structure and Function. Rodriguez, R. L., and Chamberlin, M. J. (eds.). Praeger Scientific Publ. Co., New York.
Kleid, D.G., Yansura, D., Small, B., Dowbenko, D., Moore, D.M., Grubman, M.J., McKercher, P.D., Morgan, D.O., Robertson, B.H., Bachrach, H.L. 1981. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214: 1125–1130.
Bolivar, F., Rodriguez, R.L., Greene, P.J., Betlach, M.C., Heyneker, H.L., Boyer, H.W., Crosa, J.H. and Falkow, S. 1977. Construction and characterization of new cloning vehicles II. A multipurpose cloning system. Gene 2: 95–113.
Burnette, W.N. 1981. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112: 195–203.
Mosteller, R.D., Rose, I.K. and Yanofski, C. 1970. Transcription integration and degradation of trp mRNA. Cold Spring Harbour Symp. Quant. Biol. 35: 461–466.
Winkler, M.E., Blaber, M., Bennett, G.L., Holmes, W.E. and Vehar, G.A. 1985. Purification and characterization of recombinant urokinase from E. coli. Bio/Technology, in press.
Blobel, G., Walter, P., Chang, C.N., Goldman, B.M., Erickson, A.H. and Lingappa, V.R. 1979. Translocation of proteins across membranes: the signal hypothesis and beyond. Symp. Soc. Exp. Biol. 33: 9–36.
Guenzler, W., Steffens, G., Oetting, F., Kim, S.-M., Frankus, E. and Flohé, L. 1982. The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain. Hoppe-Seyler's Z. Physiol. Chem. 363: 1155–1165.
Vehar, G.A., Kohr, W.J., Bennett, W.F., Pennica, D., Ward, C.A., Harkins, R.N. and Collen, D. 1984. Characterization studies on human melanoma cell tissue plasminogen activator. Bio/Technology 2: 1051–1057.
Magnusson, S., Sottrup-Jensen, L., Petersen, T.E., Dudek-Wojcieck, C., Owska, G. and Claeys, H. 1976. Homologous kringle structures common to plasminogen and prothrombin. Substrate specificities of enzymes activating prothrombin and plasminogen, p. 203–238. In: Proteolysis and Physiological Regulation. Ribbons, D.W. and Brew, K. (eds.). Academic Press, New York.
Sottrup-Jensen, L., Claeys, H., Zajdel, M., Petersen, T.E., Magnusson, S. 1978. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one “mini”-plasminogen (M.W. 38,000) by elastase-catalyzed specific limited proteolysis. In: Progress in chemical fibrinolysis and thrombolysis, Vol. 3. Davidson, J. F., Rowan, R. M., Samama, M. M., and Desnoyers, P. C. (eds.). Raven Press, New York.
Sottrop-Jensen, L., Zajdel, M., Claeys, H., Petersen, T.E. and Magnusson, S. 1975. Amino-acid sequence of activation cleavage site in plasminogen: homology with the “pro” part of prothrombin. Proc. Natl. Acad. Sci., USA 72: 2577–2581.
Ny, T., Elgh, F. and Lund, B. 1984. The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains. Proc. Natl. Acad. Sci., USA 81: 5355–5359.
Gilbert, W. 1978. Why genes in pieces? Nature 271: 501.
Verde, P., Stoppelli, M.P., Galeffi, P., DiNocera, P. and Blasi, F. 1984. Identification and primary sequence of an unspliced human urokinase poly(A) RNA. Proc. Natl. Acad. Sci., USA 81: 4727–4731.
Nagamine, Y., Pearson, D., Altus, M.S. and Reich, E. 1984. cDNA and gene nucleotide sequence of porcine plasminogen activator. Nucl. Acids Res. 12: 9525–9541.
Thorsen, S. 1975. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-amino-carboxylic acids. Biochim. Biophys. Acta. 393: 55–65.
Hoylaerts, M., Rijken, D.C., Lijnen, H.R. and Collen, D. 1982. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J. Biol. Chem. 257: 2912–2919.
Thorsen, S., Glas-Greenwalt, P. and Astrup, P. 1972. Differences in the binding to fibrin of urokinase and tissue plasminogen activator. Thrombosis Diastasis Haemorrhagica 28: 65–74.
Lijnen, H.R., Zamarron, C., Blaber, M., Winkler, M.E. and Collen, D. Activation of plasminogen by pro urokinase. I. Mechanism. J. Biol. Chem., accepted for publication.
Collen, D., Zamarron, C., Lijnen, H.R. and Hoylaerts, M. Activation of plasminogen by pro urokinase. II Kinetics J. Biol. Chem., accepted for publication.
Rijken, D.C., Hoylaerts, M. and Collen, D. 1982. Fibrinolytic properties of one-chain and two-chain human extrinic (tissue type) plasminogen activator. J. Biol. Chem. 257: 2920–2925.
Gurewich, V., Pannell, R., Louie, S., Kelley, P., Suddith, R.L., Greenlee, R. 1984. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase): a study in vitro and in two animal species. J. Clin. Invest. 73: 1731–1739.
Zamarron, C., Lijnen, H.R., VanHoef, B. and Collen, D. 1984. Biological and thrombolytic properties of proenzyme and active forms of human urokinase I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Throm. Haemostas. 52: 19–23.
Collen, D., Stassen, J.M., Blaber, M., Winkler, M. and Verstraete, M. 1984. Biological and thrombolytic properties of proenzyme and active forms of human urokinase III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis. Thromb. Haemostasis. 52: 27–30.
Zamarron, D., Lijnen, H.R. and Collen, D. 1985. Identification of a competitive inhibitor of pro urokinase in human plasma. Thromb. Haemostasis, in press.
Heyneker, H.L., Holmes, W.E., Rey, M., Pennica, D., Shepard, H.M., Seeburg, P., Hayflick, J., Ward, C., Vehard, G., Steffens, G., Guenzler, W., Oetting, F. and Flohé, L. 1983. Functional expression of the human urokinase gene in Escherichia coli, p. 219–221. In: Genetics of Industrial Microorganisms, 1982, Proceedings of the IVth International Symposium. Ikeda, K., and Beppu, T. (eds.). Kodansha Ltd., Tokyo.
Ratzkin, B., Lee, S.G., Schrenk, W.J., Roychoudhury, R., Chen, M., Hamilton, T.A. and Hung, P.P. 1981. Expression in Escherichia coli of biologically active enzyme by a DNA sequence coding for the human plasminogen activator urokinase. Proc. Natl. Acad. Sci. USA 78: 3313–3317.
Aviv, H. and Leder, P. 1972. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA 69: 1408–1412.
Taylor, J.M., Illmensee, R. and Summers, J. 1976. Efficient transcription of RNA into DNA by avian sarcoma virus polymerase. Biochim. Biophys. Acta 442: 324–330.
Smith, A.J.H. 1980. DNA sequence analysis by primed synthesis. Meth. Enzymol. 65: 560–580.
Messing, J., Crea, R. and Seeburg, P.H. 1981. A system for shotgun DNA sequencing. Nucl. Acids Res. 9: 309–321.
Crea, R. and Horn, T. 1980. Synthesis of oligonucleotides on cellulose by a phosphotriester method. Nucl. Acids Res. 8: 2331–2348.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
Ploug, J. and Kjeldgaard, N.O. 1957. Urokinase: an activator of plasminogen from human urine. I, isolation and properties. Biochim. Biophys. Acta 24: 278–282.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holmes, W., Pennica, D., Blaber, M. et al. Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli. Nat Biotechnol 3, 923–929 (1985). https://doi.org/10.1038/nbt1085-923
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1085-923
- Springer Nature America, Inc.
This article is cited by
-
Physiology and pathophysiology of the plasminogen system in the kidney
Pflügers Archiv - European Journal of Physiology (2017)
-
Streptokinase—the drug of choice for thrombolytic therapy
Journal of Thrombosis and Thrombolysis (2007)
-
Secretion of active urokinase-type plasminogen activator from the yeastYarrowia lipolytica
Biotechnology and Bioprocess Engineering (2003)